Correction: Differentiating HER2-low and HER2-zero tumors with 21-gene multigene assay in 2,295 HR + HER2- breast cancer: a retrospective analysis (Breast Cancer Research, (2024), 26, 1, (154), 10.1186/s13058-024-01911-9)

Yoonwon Kook; Young Jin Lee; Chihhao Chu; Ji Soo Jang; Seung Ho Baek; Soong June Bae; Yoon Jin Cha; Gyungyup Gong; Joon Jeong; Sae Byul Lee; Sung Gwe Ahn

doi:10.1186/s13058-024-01929-z

Correction: Differentiating HER2-low and HER2-zero tumors with 21-gene multigene assay in 2,295 HR + HER2- breast cancer: a retrospective analysis (Breast Cancer Research, (2024), 26, 1, (154), 10.1186/s13058-024-01911-9)

Yoonwon Kook, Young Jin Lee, Chihhao Chu, Ji Soo Jang, Seung Ho Baek, Soong June Bae, Yoon Jin Cha, Gyungyup Gong, Joon Jeong, Sae Byul Lee, Sung Gwe Ahn

Department of Surgery

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Following the publication of the original article, the authors reported an error in the title due to typesetting mistake. HR + was wrongly typeset as h+. The title of this Correction is correct, and the original article has been corrected.

Original language	English
Article number	164
Journal	Breast Cancer Research
Volume	26
Issue number	1
DOIs	https://doi.org/10.1186/s13058-024-01929-z
Publication status	Published - 2024 Dec

Bibliographical note

Publisher Copyright:
© The Author(s) 2024.

All Science Journal Classification (ASJC) codes

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/s13058-024-01929-z

Fingerprint

Dive into the research topics of 'Correction: Differentiating HER2-low and HER2-zero tumors with 21-gene multigene assay in 2,295 HR + HER2- breast cancer: a retrospective analysis (Breast Cancer Research, (2024), 26, 1, (154), 10.1186/s13058-024-01911-9)'. Together they form a unique fingerprint.

Cite this

Kook, Y., Lee, Y. J., Chu, C., Jang, J. S., Baek, S. H., Bae, S. J., Cha, Y. J., Gong, G., Jeong, J., Lee, S. B., & Ahn, S. G. (2024). Correction: Differentiating HER2-low and HER2-zero tumors with 21-gene multigene assay in 2,295 HR + HER2- breast cancer: a retrospective analysis (Breast Cancer Research, (2024), 26, 1, (154), 10.1186/s13058-024-01911-9). Breast Cancer Research, 26(1), Article 164. https://doi.org/10.1186/s13058-024-01929-z

@article{d3f2f2d3c66b467194630c3eeebc4b32,

title = "Correction: Differentiating HER2-low and HER2-zero tumors with 21-gene multigene assay in 2,295 HR + HER2- breast cancer: a retrospective analysis (Breast Cancer Research, (2024), 26, 1, (154), 10.1186/s13058-024-01911-9)",

abstract = "Following the publication of the original article, the authors reported an error in the title due to typesetting mistake. HR + was wrongly typeset as h+. The title of this Correction is correct, and the original article has been corrected.",

author = "Yoonwon Kook and Lee, {Young Jin} and Chihhao Chu and Jang, {Ji Soo} and Baek, {Seung Ho} and Bae, {Soong June} and Cha, {Yoon Jin} and Gyungyup Gong and Joon Jeong and Lee, {Sae Byul} and Ahn, {Sung Gwe}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

year = "2024",

month = dec,

doi = "10.1186/s13058-024-01929-z",

language = "English",

volume = "26",

journal = "Breast Cancer Research",

issn = "1465-5411",

publisher = "BioMed Central",

number = "1",

}

Kook, Y, Lee, YJ, Chu, C, Jang, JS, Baek, SH, Bae, SJ, Cha, YJ, Gong, G, Jeong, J, Lee, SB & Ahn, SG 2024, 'Correction: Differentiating HER2-low and HER2-zero tumors with 21-gene multigene assay in 2,295 HR + HER2- breast cancer: a retrospective analysis (Breast Cancer Research, (2024), 26, 1, (154), 10.1186/s13058-024-01911-9)', Breast Cancer Research, vol. 26, no. 1, 164. https://doi.org/10.1186/s13058-024-01929-z

Correction: Differentiating HER2-low and HER2-zero tumors with 21-gene multigene assay in 2,295 HR + HER2- breast cancer: a retrospective analysis (Breast Cancer Research, (2024), 26, 1, (154), 10.1186/s13058-024-01911-9). / Kook, Yoonwon; Lee, Young Jin; Chu, Chihhao et al.
In: Breast Cancer Research, Vol. 26, No. 1, 164, 12.2024.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Correction

T2 - Differentiating HER2-low and HER2-zero tumors with 21-gene multigene assay in 2,295 HR + HER2- breast cancer: a retrospective analysis (Breast Cancer Research, (2024), 26, 1, (154), 10.1186/s13058-024-01911-9)

AU - Kook, Yoonwon

AU - Lee, Young Jin

AU - Chu, Chihhao

AU - Jang, Ji Soo

AU - Baek, Seung Ho

AU - Bae, Soong June

AU - Cha, Yoon Jin

AU - Gong, Gyungyup

AU - Jeong, Joon

AU - Lee, Sae Byul

AU - Ahn, Sung Gwe

PY - 2024/12

Y1 - 2024/12

N2 - Following the publication of the original article, the authors reported an error in the title due to typesetting mistake. HR + was wrongly typeset as h+. The title of this Correction is correct, and the original article has been corrected.

AB - Following the publication of the original article, the authors reported an error in the title due to typesetting mistake. HR + was wrongly typeset as h+. The title of this Correction is correct, and the original article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85210436354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85210436354&partnerID=8YFLogxK

U2 - 10.1186/s13058-024-01929-z

DO - 10.1186/s13058-024-01929-z

M3 - Comment/debate

C2 - 39593071

AN - SCOPUS:85210436354

SN - 1465-5411

VL - 26

JO - Breast Cancer Research

JF - Breast Cancer Research

IS - 1

M1 - 164

ER -